Bridgefront Capital’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
CS
Bridgefront Capital's GH Position: Q1 2023 in Review
Bridgefront Capital sold out of Guardant Health (GH) in Q1 2023, closing a stake of 14,882 shares — an estimated $405K sold.
Bridgefront Capital first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $405K in Q4 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.
- Bridgefront Capital reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
- Bridgefront Capital sold 14,882 Guardant Health shares in Q1 2023, an estimated $405K.
- Bridgefront Capital first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
- Bridgefront Capital's Guardant Health position peaked at $405K in Q4 2022.
- 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.
Based on Bridgefront Capital's 13F filing for Q1 2023, filed 15 May 2023.